GLOBAL HEALTH LIMITED
₹ 319 - ₹ 336
03-Nov-2022 - 07-Nov-2022
₹ 14784.00

/ 44 Shares

GLOBAL HEALTH LIMITED

03-Nov-2022 - 07-Nov-2022

₹ 319 - ₹ 336

Price Band

₹ 14784.00

Minimum Investment

44

Bid Lot

65,641,952

Shares

  • Face Value - ₹ 2/- Per Share

  • Listing at NSE BSE

  • 522,151 Application Required in Retail for 1 Time.

  • Registrar : KFin Technologies Limited

IPO Details

Fresh Issue of Equity shares aggregating upto Rs. 500 Cr and offer for sale of 50,761,000 Equity Shares

Category % Shares/Amount
QIB 50% 32,820,975 Shares Rs. 1102.75 Cr
HNI 1 5% 3,282,098 Shares Rs. 110.28 Cr @ 5328 Forms 1x
HNI 2 10% 6,564,195 Shares Rs. 220.56 Cr @ 10656 Forms 1x
Retail 35% 22,974,684 Shares Rs. 771.90 Cr @ 522151 Forms 1x

BRLMs : Kotak Mahindra Capital, Credit Suisse, Jefferies India, JM Financial Services Ltd

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
522151 5328 10656

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 44 ₹ 14,784
Retail (Upto 2 Lakh) 13 572 ₹ 192,192
S-HNI (2 Lakh to 10 Lakh) 14 616 ₹ 206,976
S-HNI (2 Lakh to 10 Lakh) 67 2948 ₹ 990,528
B-HNI (Above 10 Lakh) 68 2992 ₹ 1,005,312

IPO Timeline

  • Open Date

    03-Nov-2022

  • Close Date

    07-Nov-2022

  • Basis of Allotment Date

    11-Nov-2022

  • Initiation of Refunds

    14-Nov-2022

  • Credit Shares to Demat A/c

    15-Nov-2022

  • IPO Listing Date

    16-Nov-2022

Subscription as on
08-Nov-2022 15:29

Category Book Size Subscription No. of Times
QIB 13,128,390 ₹ 441.11 Cr. 214,919,408 ₹ 7221.29 Cr. 16.37x
HNI (<10 LAKH) 3,282,098 ₹ 110.28 Cr. 3,365,120 ₹ 113.07 Cr. 1.03x
HNI2 (>10 LAKH) 6,564,195 ₹ 220.56 Cr. 20,656,592 ₹ 694.06 Cr. 3.15x
RETAIL 22,974,684 ₹ 771.95 Cr. 11,828,300 ₹ 397.43 Cr. 0.51x
Total 45,949,367 250,769,420 5.46x
Category Book Size Subscription No. of Times
QIB 13,128,390 ₹ 441.11 Cr. 214,919,408 ₹ 7221.29 Cr. 16.37x
HNI (<10 LAKH) 3,282,098 ₹ 110.28 Cr. 3,365,120 ₹ 113.07 Cr. 1.03x
HNI2 (>10 LAKH) 6,564,195 ₹ 220.56 Cr. 20,656,592 ₹ 694.06 Cr. 3.15x
RETAIL 22,974,684 ₹ 771.95 Cr. 11,828,300 ₹ 397.43 Cr. 0.51x
Total 45,949,367 250,769,420 5.46x

*Excluding Anchor

Total No. of Application Approx : ~168268 (0.32 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • Founded by Dr. Naresh Trehan, Global Health Ltd (“Medanta”) was incorporated on August 13, 2004. Medanta is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
  • Medanta has a network of 5 hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna), and 1 hospital (Noida), which is under construction. As of June 30, 2022, they provide healthcare services in over 30 medical specialties and engages over 1,300 doctors led by highly experienced department heads and, spanning an area of 4.7 msf, their operational hospitals have 2,467 installed beds.
  • As of March 31, 2020, Medanta had 2,141 installed beds, which grew to 2,467 installed beds as of June 30, 2022, representing a growth of 15.23%. Upon operation of their Noida hospital, Medanta expects the number of total installed beds to exceed 3,500 at the end of Fiscal 2025, which will cater to domestic and international patients as part of their strategy to capitalize on medical tourism.
  • Their hospital at Gurugram was ranked as the best private hospital in India for 3 consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of Top-200 global hospitals in 2021 and was featured in the list of Top-250 global hospitals in 2022 by Newsweek.
  •  In Fiscal 2021, Medanta took the out-patient department pharmacies in-house at their Gurugram, Lucknow, Indore, and Ranchi hospitals, and launched out-patient department pharmacy at south Delhi clinic and home care services in Gurugram and New Delhi. In Fiscal 2022, they launched the out-patient department pharmacy at their Patna hospital
Read More

Strengths

  • Leading tertiary and quaternary care provider in India, well recognised for clinical expertise in particular in dealing with complicated cases.
  • Focus on Clinical Research and Academics.
  • Large-scale hospitals with world-class infrastructure, high-end medical equipment, and technology.
  • Track record of strong operational and financial performance.
  • Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna).
  • Growth opportunities in existing facilities and diversification into new services, including digital health.
  • Experienced senior management team with strong institutional shareholder support.

Company Promoters

Dr. Naresh Trehan is the Chairman and Managing Director of the company. Sunil Sachdeva is the Non-Executive Director of the company. Ravi Kant Jaipuria is the Non-Executive Nominee Director of the company. Venkatesh Ratnasami is the Non-Executive Nominee Director of the company. Praveen Mahajan is the Non-Executive Independent Director of the company. Vikram Singh Mehta is the Non-Executive Independent Director of the company. Hari Shanker Bhartia is the Non-Executive Independent Directo

Company Financials

Company Financials

 
Period Ended Total Assets Total Revenue Profit After Tax Net Worth Total Borrowing
31-Mar-20 2666.29 1544.27 36.33 1349.54 621.94
30-Jun-20 2855.11 491.58 41.76 1425.38 725.07
31-Mar-21 2694.1 1478.16 28.8 1382.34 644.6
31-Mar-22 3145.52 2205.82 196.2 1616.01 837.86
30-Jun-22 3221.94 626.54 58.71 1675.55 794.45
Amount in ? Crore

Objects of the Issue

  • Investment in two of their subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment /prepayment of borrowings, in full or part, of such Subsidiaries;
  • General Corporate Purposes

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment
Message!!

Your file has been successfully uploaded.